Jiangxi Synergy Pharmaceutical Co., Ltd.
SZSE:300636.SZ
10.41 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 512.753 | 141.964 | 161.291 | 280.404 | 38.266 | 39.867 | 23.937 | 58.19 | 19.497 | 11.262 | 15.379 | 7.867 |
| Short Term Investments
| -0 | 0 | 0 | 0 | 0 | 37 | 217.4 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 512.753 | 141.964 | 161.291 | 280.404 | 38.266 | 39.867 | 23.937 | 58.19 | 19.497 | 11.262 | 15.379 | 7.867 |
| Net Receivables
| 87.923 | 107.488 | 73.4 | 25.328 | 76.052 | 38.159 | 52.071 | 26.006 | 31.973 | 28.625 | 12.668 | 15.38 |
| Inventory
| 523.417 | 497.358 | 373.422 | 335.414 | 240.127 | 156.555 | 138.075 | 128.406 | 93.351 | 70.939 | 67.151 | 49.351 |
| Other Current Assets
| 72.89 | 11.135 | 35.443 | 24.05 | 26.569 | 57.743 | 219.335 | 0.931 | 2.666 | 5.512 | 11.603 | 6.35 |
| Total Current Assets
| 1,196.984 | 757.946 | 643.557 | 665.196 | 381.014 | 292.323 | 433.418 | 213.532 | 147.487 | 116.338 | 106.801 | 78.948 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1,514.122 | 1,421.738 | 1,217.53 | 754.68 | 599.219 | 477.52 | 245.659 | 196.585 | 193.572 | 131.422 | 121.292 | 98.774 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 20.167 | 21.077 | 21.435 | 22.035 | 23.179 | 24.114 | 22.2 | 6.405 | 5.13 | 5.291 | 5.331 | 5.46 |
| Goodwill and Intangible Assets
| 20.167 | 21.077 | 21.435 | 22.035 | 23.179 | 24.114 | 22.2 | 6.405 | 5.13 | 5.291 | 5.331 | 5.46 |
| Long Term Investments
| 488.842 | 51.176 | -0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 0 | 0 |
| Tax Assets
| 0.232 | 0.13 | 0.153 | 0.094 | 0.124 | 0.178 | 1.15 | 0.337 | 0.401 | 0.257 | 0.556 | 0.631 |
| Other Non-Current Assets
| 1.094 | 6.788 | 24.052 | 25.664 | 12.175 | 9.484 | 19.851 | 2.101 | 2.055 | 3.995 | 1.453 | 5.012 |
| Total Non-Current Assets
| 2,024.456 | 1,500.909 | 1,263.171 | 802.473 | 634.697 | 511.295 | 288.86 | 205.429 | 201.158 | 140.964 | 128.631 | 109.876 |
| Total Assets
| 3,221.44 | 2,258.855 | 1,906.728 | 1,467.669 | 1,015.711 | 803.618 | 722.278 | 418.961 | 348.645 | 257.302 | 235.433 | 188.824 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 130.393 | 212.824 | 143.783 | 30.89 | 62.152 | 80.343 | 29.501 | 43.76 | 43.749 | 31.722 | 21.169 | 26.35 |
| Short Term Debt
| 516.922 | 284.891 | 187.352 | 209.371 | 93.806 | 20 | 26.588 | 29.832 | 36.563 | 87.539 | 83.798 | 53.7 |
| Tax Payables
| 1.668 | 1.093 | 0.68 | 0.456 | 0.629 | 0.603 | 2.705 | 4.64 | 0.522 | 0.447 | 0.232 | 0.093 |
| Deferred Revenue
| 2.087 | 11.687 | 10.031 | 3.477 | 27.504 | 0.603 | 1.153 | 13.876 | 8.858 | 12.702 | 26.906 | 48.523 |
| Other Current Liabilities
| 52.309 | 65.634 | 19.501 | 14.371 | 4.604 | 41.933 | 6.129 | 0.953 | 1.052 | 0.313 | 1.27 | 1.242 |
| Total Current Liabilities
| 701.711 | 575.036 | 360.668 | 258.109 | 188.066 | 142.879 | 63.372 | 88.422 | 90.222 | 132.277 | 133.143 | 129.814 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 252.038 | 329.242 | 623.423 | 365.599 | 114.3 | 0 | 20 | 25 | 8 | 7 | 22 | 13.5 |
| Deferred Revenue Non-Current
| 4.018 | 4.028 | 4.188 | 4.348 | 1.941 | 0.789 | 0.836 | 0.884 | 0.931 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 37.223 | 30.881 | 30.336 | 23.111 | 5.096 | 1.79 | 0.968 | -25 | -5.168 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25 | 8 | 0 | 1.474 | -13.5 |
| Total Non-Current Liabilities
| 293.279 | 364.151 | 657.947 | 393.059 | 121.337 | 2.579 | 21.805 | 25.884 | 11.764 | 7 | 23.474 | 13.5 |
| Total Liabilities
| 994.991 | 939.187 | 1,018.615 | 651.168 | 309.403 | 145.458 | 85.177 | 114.305 | 101.986 | 139.277 | 156.616 | 143.314 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0.188 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 423.136 | 350.19 | 205.906 | 128.62 | 80.951 | 81.395 | 81.298 | 60 | 60 | 31.8 | 31.8 | 15 |
| Retained Earnings
| 496.028 | 416.391 | 338.758 | 276.633 | 224.537 | 184.371 | 171.231 | 112.187 | 59.895 | 64.944 | 29.582 | 27.259 |
| Accumulated Other Comprehensive Income/Loss
| -0 | 27.041 | 91.906 | 84.087 | 16.297 | 6.658 | -0.188 | 132.468 | 126.764 | 0 | -0 | 0 |
| Other Total Stockholders Equity
| 1,307.285 | 526.046 | 251.543 | 327.161 | 384.524 | 385.736 | 384.572 | 0 | 0 | 21.281 | 17.435 | 3.251 |
| Total Shareholders Equity
| 2,226.449 | 1,319.669 | 888.113 | 816.501 | 706.308 | 658.16 | 637.101 | 304.655 | 246.659 | 118.025 | 78.817 | 45.51 |
| Total Equity
| 2,226.449 | 1,319.669 | 888.113 | 816.501 | 706.308 | 658.16 | 637.101 | 304.655 | 246.659 | 118.025 | 78.817 | 45.51 |
| Total Liabilities & Shareholders Equity
| 3,221.44 | 2,258.855 | 1,906.728 | 1,467.669 | 1,015.711 | 803.618 | 722.278 | 418.961 | 348.645 | 257.302 | 235.433 | 188.824 |